Current FDA approved weight loss meds Wegovy and Zepbound are weekly injections.
In this file photo, a person walks past the Pfizer Headquarters building in the Manhattan borough of New York City, Dec. 7, 2020.Pfizer announced early Thursday morning that it has selected its preferred once-daily modified release formulation of danuglipron, a move that it said was a significant milestone in the obesity drug’s development.
Danuglipron, an oral glucagon-like peptide-1 receptor agonist, will undergo dose optimization studies in the second half of 2024 as Pfizer seeks to evaluate multiple doses of the formulation which they hope will inform the registration-enabling studies. “Obesity is a key therapeutic area for Pfizer, and the company has a robust pipeline of three clinical and several pre-clinical candidates. The most advanced of them, danuglipron, has demonstrated good efficacy in a twice-daily formulation, and we believe a once-daily formulation has the potential to have a competitive profile in the oral GLP-1 space,” said Mikael Dolsten, MD., PhD., chief scientific officer & president, Pfizer Research and Development.
In this file photo, a person walks past the Pfizer Headquarters building in the Manhattan borough of New York City, Dec. 7, 2020.Participants in the study so far have included healthy adults aged 18 years or older and the results thus far have shown a profile that supports once-daily dosing, which is consistent with previous danuglipron studies. Notably, there have been no liver enzyme elevations observed among the more than 1,400 study participants.
Danuglipron is an investigational medicine that is taken as a tablet by mouth and is currently not approved for use by health authorities.Pfizer will still need to do large scale clinical trials to produce the data necessary to show it’s safe, effective and tolerable and then submit to FDA -- a process which is still likely much further down the line.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Current beach conditions: Rip current risks through today; is water open?Water is reopening along the Gulf Coast though officials continue to warn of the potential for dangerous rip currents and strong tides.
Read more »
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid declineCNBC spoke with 11 current and former Pfizer employees, who asked to remain anonymous, about Pfizer’s dizzying climb, rapid decline and turnaround…
Read more »
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid declineCNBC spoke with 11 current and former Pfizer employees, who asked to remain anonymous, about Pfizer’s dizzying climb, rapid decline and turnaround…
Read more »
FDA: Severe Illness From Psychedelic Candy Now Seen in 20 StatesThe Best in Science News and Amazing Breakthroughs
Read more »
Tampons are the latest victim of shrinkflation, women allege — as makers say no way: 'Insidious'FDA approves new 'spiral' tampon shape
Read more »
FDA Warns Top National Bakery to Stop Listing Allergens in Products When They Aren't ThereThe U.S. Food and Drug Administration has sent a warning letter to one of America's biggest bakeries, asking the company to stop claiming there are allergens such as sesame or nuts in products when in fact they are not there.
Read more »